This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Social selling: la influencia de la redes sociales en la venta
Chiesa de Negri, Cosimo; Morales, LaiaTechnical Note MN-395Innovation and Change, Leadership and People Management, StrategyEn estos últimos años, estamos viviendo una acelerada transformación en muchos aspectos de nuestra vida profesional y personal. Esto se debe, en gran parte, a la incorporación de las nuevas tecnologías en nuestra rutina diaria. Vivimos en un entorno de cambio constante en el que hemos modificado nuestra manera de comunicarnos, de comportarnos, de relacionarnos, de interactuar o de informarnos, y todo ello, a un ritmo vertiginoso. Aun así, según ...Starting at €8.20
-
U.S. Universities and Technology Transfer
Hamermesh, Richard G.; Lerner, Josh; Andrews, PhillipCase HBS-812016-EEntrepreneurshipTechnology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the growth of technology transfer offices, and compares how three different universities (MIT, Stanford, and Harvard) approach technology transfer. Provides an overview of the technology tra...Starting at €8.20
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
Syndexa and Technology Transfer at Harvard University
Hamermesh, Richard G.; Kiron, DavidCase HBS-808073-EGokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the head of Harvard's Office of Technology Development (OTD) is eager to improve Harvard's record in commercializing science. Describes the negotiations between Hotamisligil, OTD, the ne...Starting at €8.20
-
Artificial Intelligence for the Real World
Davenport, Thomas H.; Ronanki, RajeevArticle HBS-R1801H-EInformation TechnologiesCognitive technologies are increasingly being used to solve business problems; indeed, many executives believe that AI will substantially transform their companies within three years. But many of the most ambitious AI projects encounter setbacks or fail. A survey of 250 executives familiar with their companies' use of cognitive technology and a study of 152 projects show that companies do better by taking an incremental rather than a transformati...Starting at €8.20
-
How to Design Smart Business Experiments (Spanish version)
Davenport, Thomas H.Article HBS-R0902EStrategyManagers regularly implement new ideas without evidence to back them up. They act on hunches and often learn very little along the way. That doesn't have to be the case. With the help of broadly available software and some basic investments in building capabilities, managers don't need a PhD in statistics to base consequential decisions on scientifically sound experiments. Some companies with rich consumer-transaction data - Toronto-Dominion, CKE...Starting at €8.20
-
Competing on Talent Analytics (Spanish version)
Davenport, Thomas H.; Harris, Jeanne; Shapiro, JeremyArticle HBS-R1010BStrategyDo investments in your employees actually affect workforce performance? Who are your top performers? How can you empower and motivate other employees to excel? Leading edge companies such as Google, Best Buy, P&G, and Sysco use sophisticated data-collection technology and analysis to answer these questions, leveraging a range of analytics to improve the way they attract and retain talent, connect their employee data to business performance, diffe...Starting at €8.20
-
The HBR Agenda 2011 (Spanish version)
Ariely, Dan; Brown, Tim; Cappelli, Peter; Davenport, Thomas H.; Duflo, Esther; Fernández-Aráoz, Claudio; Govindarajan, Vijay; Gratton, Lynda; Hackman, J. Richard; Ibarra, Herminia; Kedrosky, Paul; Lafley, A.G.; Li, Charlene; Ma, Jack; Manzoni, Jean-Francois; Pink, Daniel H.; Porter, Michael E.; Schein, Edgar H.; Schmidt, Eric; Schwab, Klaus; Shirky, Clay; Stiglitz, Joseph E.; Sutton, Robert I.; Tyson, LaArticle HBS-R1101BKnowledge and CommunicationJoseph E. Stiglitz will be crafting a new postcrisis paradigm for macroeconomics whereby rational individuals interact with imperfect and asymmetric information. Herminia Ibarra will be looking for hard evidence of how "soft" leadership creates value. Eric Schmidt will be planning to scale mobile technology by developing fast networks and providing low-cost smartphones in the poorest parts of the world. Michael Porter will be using modern cost a...Starting at €8.20
-
Keeping Up with the Quants 7. Working with Quants
Davenport, Thomas H.; Kim, JinhoBook Chapter HBS-7700BC-EKeeping Up with the Quants is a seven-chapter book published in 2013 by the Harvard Business Review Press and written by Thomas Davenport, Professor of IT and Management at Babson College, and Jinho Kim, Professor of Business and Statistics at Korea National Defense University. Written for non-analysts and "non-quants," this book is a guide to summarizing data, interpreting its meaning, and using it in decision-making. The authors explain that a ...Starting at €8.20
-
Lyric Dinner Theater (B) (Spanish version)
Hamermesh, Richard G.; Sharpe, James M.Case HBS-815S17EntrepreneurshipSuplementos el caso (A). Rivka Belzer refleja en los resultados y las medidas adoptadas durante los 12 meses siguientes a su primer 6 meses en el trabajo. Suplementos el caso (A). Rivka Belzer tomó un trabajo en su empresa familiar y trabajó diligentemente durante los primeros 6 meses para convertir el negocio alrededor. Este caso suplementario esboza una serie de decisiones que hizo después de los 6 meses y reporta los resultados financieros un ...Starting at €5.74